Profile
Prior to joining Oaktree in 2006, Mr. Meng Gao served as an Associate in the Natural Resources and Industrials Groups at J.P.
Morgan Securities in New York.
Prior to that, he was a Financial Analyst in the Mergers and Acquisitions and Retail Groups at Credit Suisse First Boston in New York.
Mr. Meng Gao received a Bachelor of Economics degree in International Finance from Peking University, an M.A.
degree in International Relations from Yale University and an M.B.A.
with honors in Finance and Entrepreneurial Management from the Wharton School at the University of Pennsylvania.
He is a native Mandarin speaker and is fluent in English.
Meng Gao active positions
| Companies | Position | Start |
|---|---|---|
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Director of Finance/CFO | - |
Former positions of Meng Gao
| Companies | Position | End |
|---|---|---|
Oaktree Capital (Hong Kong) Ltd.
 Oaktree Capital (Hong Kong) Ltd. Investment ManagersFinance Oaktree Capital (Hong Kong) Ltd. (Oaktree-Hong Kong) is the subsidiary of Oaktree Capital Management LP in the US, founded in1995 by Howard Marks, Bruce Karsh, Steve Kaplan, Larry Keele, Richard Masson and Sheldon Stone.. Established in 2005, the Hong Kong subsidiary aims to provide investment management in a limited number of specialized niche markets where they believe the potential for reward outweighs the risk. | Director/Board Member | 2011-03-30 |
Arctic Vision (Shanghai) Biotechnology Co., Ltd.
 Arctic Vision (Shanghai) Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a Chinese Shanghai-based ophthalmic biotech company that focuses on developing innovative therapies to address unmet clinical needs and benefit ophthalmic patients. The company is led by an elite team of ophthalmic industry veterans with substantial experience in R&D and commercialization of eye care products. Arctic Vision has top-tier biotech venture capital investors with a broad network in both the U.S. and European ophthalmic markets, and an unprecedented track record in company incubation. The company was founded by Hai Di Hu, who has been the CEO since incorporation. | Private Equity Investor | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Oaktree Capital (Hong Kong) Ltd.
Oaktree Capital (Hong Kong) Ltd. Investment ManagersFinance Oaktree Capital (Hong Kong) Ltd. (Oaktree-Hong Kong) is the subsidiary of Oaktree Capital Management LP in the US, founded in1995 by Howard Marks, Bruce Karsh, Steve Kaplan, Larry Keele, Richard Masson and Sheldon Stone.. Established in 2005, the Hong Kong subsidiary aims to provide investment management in a limited number of specialized niche markets where they believe the potential for reward outweighs the risk. | Finance |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Finance |
Arctic Vision (Shanghai) Biotechnology Co., Ltd.
Arctic Vision (Shanghai) Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a Chinese Shanghai-based ophthalmic biotech company that focuses on developing innovative therapies to address unmet clinical needs and benefit ophthalmic patients. The company is led by an elite team of ophthalmic industry veterans with substantial experience in R&D and commercialization of eye care products. Arctic Vision has top-tier biotech venture capital investors with a broad network in both the U.S. and European ophthalmic markets, and an unprecedented track record in company incubation. The company was founded by Hai Di Hu, who has been the CEO since incorporation. | Health Technology |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Meng Gao
